Meniscectomy Clinical Trial
Official title:
Dose Response of Ketorolac in Out-Patients Undergoing Knee Arthroscopy
Ketorolac is administered as current practice to the majority of patients undergoing knee arthroscopy, the appropriate dose of ketorolac to be administered has not been evaluated.
Past studies have examined different doses of ketorolac administered to patients after spinal fusion surgery and found that 7.5 mg every 6 hours was as effective as 15 or 30 mg every 6 hours in decreasing postoperative pain and patient opiate consumption. Since ketorolac side effects such as gastrointestinal and surgical site bleeding seem to be dose related, utilizing a lower dose of ketorolac may be more efficacious. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01879852 -
Muscle Weakness and Post-traumatic Knee OA
|
N/A | |
Terminated |
NCT03696836 -
AIR (Artificial Implant for Medial Meniscus Replacement) Study
|
N/A | |
Completed |
NCT04644640 -
Telerehabilitation Following Meniscectomy
|
N/A | |
Recruiting |
NCT04972331 -
Degenerative Meniscus Without Osteoarthritis : Arthroscopic Partial Menisectomy Versus Platelet Rich Plasma (APM-PRP)
|
N/A | |
Completed |
NCT03350204 -
Biomechanical Osteoarthritis Outcomes in Meniscectomy Patients
|
N/A | |
Completed |
NCT02136901 -
The VENUS Clinical Study (Verifying the Effectiveness of the NUsurface® System)
|
N/A | |
Completed |
NCT02108496 -
Verifying the Effectiveness of the NUsurface® System
|
N/A | |
Completed |
NCT01158677 -
Short Term Outcome After Meniscectomy
|
||
Completed |
NCT02872753 -
Intra-operative Injection of Autologous Conditioned Plasma (ACP) Following Partial Meniscectomy
|
Phase 4 | |
Enrolling by invitation |
NCT04717609 -
Saphenous Nerve Block for Partial Meniscectomy
|
Phase 3 | |
Completed |
NCT01571102 -
Impact of Physiotherapy on Short-term Outcome After Meniscectomy
|
N/A | |
Terminated |
NCT00314457 -
Efficacy Study of Continuous Intraarticular Infusion in Patients Undergoing Arthroscopic Knee and Shoulder Operations
|
Phase 4 |